These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 15964288

  • 1. Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women.
    Aktun H, Moroy P, Cakmak P, Yalcin HR, Mollamahmutoglu L, Danisman N.
    Contraception; 2005 Jul; 72(1):24-7. PubMed ID: 15964288
    [Abstract] [Full Text] [Related]

  • 2. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 3. Depo-Provera use in an Australian metropolitan practice.
    Fraser IS, Dennerstein GJ.
    Med J Aust; 1994 May 02; 160(9):553-6. PubMed ID: 8164553
    [Abstract] [Full Text] [Related]

  • 4. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M, Guarnaccia M, Alon J, Wiley J.
    Fam Plann Perspect; 1996 May 02; 28(4):174-8. PubMed ID: 8853283
    [Abstract] [Full Text] [Related]

  • 5. Experience with the use of depo-medroxyprogesterone acetate in a Nigerian population.
    Falase EA, Otolorin EO, Ladipo OA.
    Afr J Med Med Sci; 1988 Dec 02; 17(4):209-13. PubMed ID: 2854367
    [Abstract] [Full Text] [Related]

  • 6. [Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland].
    Lech MM.
    Wiad Lek; 2003 Dec 02; 56(7-8):362-8. PubMed ID: 14969166
    [Abstract] [Full Text] [Related]

  • 7. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM.
    Int J Fertil Womens Med; 1998 Dec 02; 43(2):73-83. PubMed ID: 9609206
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and acceptability of depo-medroxyprogesterone acetate injection. As a method of contraception in Saudi Arabia.
    Sobande AA, Al-Bar HM, Archibong EI, Sadek AA.
    Saudi Med J; 2000 Apr 02; 21(4):348-51. PubMed ID: 11533816
    [Abstract] [Full Text] [Related]

  • 9. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
    Hu E, Ikeako LC, Obiora-Okafor NC.
    Niger J Med; 2012 Apr 02; 21(3):266-71. PubMed ID: 23304918
    [Abstract] [Full Text] [Related]

  • 10. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
    Nelson AL.
    J Reprod Med; 1996 May 02; 41(5 Suppl):391-400. PubMed ID: 8725701
    [Abstract] [Full Text] [Related]

  • 11. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
    Harel Z, Biro FM, Kollar LM.
    J Adolesc Health; 1995 May 02; 16(5):379-84. PubMed ID: 7662688
    [Abstract] [Full Text] [Related]

  • 12. Long-term contraception with Depo-Provera: a clinical evaluation.
    Mukherjea M, Mukherjee P, Biswas R.
    Int J Fertil; 1980 May 02; 25(2):122-6. PubMed ID: 6117526
    [Abstract] [Full Text] [Related]

  • 13. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
    Harel Z, Biro FM, Kollar LM, Rauh JL.
    J Adolesc Health; 1996 Aug 02; 19(2):118-23. PubMed ID: 8863083
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of injectable contraceptive users in a low-income population in Texas.
    Sangi-Haghpeykar H, Poindexter AN, Moseley DC, Bateman L, Reid ED.
    Fam Plann Perspect; 1995 Aug 02; 27(5):208-11, 225. PubMed ID: 9104608
    [Abstract] [Full Text] [Related]

  • 15. Demographic analysis of post-abortive and interval-administered hormonal contraceptive methods.
    Ertopçu K, Inal MM, Ozelmas I.
    Eur J Contracept Reprod Health Care; 2005 Mar 02; 10(1):1-5. PubMed ID: 16036290
    [Abstract] [Full Text] [Related]

  • 16. Long-acting contraceptive options.
    Kaunitz AM.
    Int J Fertil Menopausal Stud; 1996 Mar 02; 41(2):69-76. PubMed ID: 8829701
    [Abstract] [Full Text] [Related]

  • 17. [An introductory clinical trial of three-monthly injectable contraceptive-depot medroxyprogesterone acetate].
    Shao Q, Jiang H, Fu W.
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jan 02; 34(1):36-9. PubMed ID: 11263172
    [Abstract] [Full Text] [Related]

  • 18. Contraceptive efficacy and safety of DMPA-SC.
    Jain J, Jakimiuk AJ, Bode FR, Ross D, Kaunitz AM.
    Contraception; 2004 Oct 02; 70(4):269-75. PubMed ID: 15451329
    [Abstract] [Full Text] [Related]

  • 19. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
    Potter LS, Dalberth BT, Cañamar R, Betz M.
    Contraception; 1997 Nov 02; 56(5):305-12. PubMed ID: 9437559
    [Abstract] [Full Text] [Related]

  • 20. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
    Thurman AR, Hammond N, Brown HE, Roddy ME.
    J Pediatr Adolesc Gynecol; 2007 Apr 02; 20(2):61-5. PubMed ID: 17418388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.